Global Pharmaceutical Manufacturing Market 2022-2028
The global pharmaceutical manufacturing market is projected to rise by USD 421.0 billion by 2028, according to a new report by Gen Consulting Company. It is anticipated to expand at a CAGR of 11 percent during the forecast period.
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global pharmaceutical manufacturing market. It traces the market’s historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the pharmaceutical manufacturing industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the drug development type, formulation, administration route, prescription, therapy area, age type, and region. The global market for pharmaceutical manufacturing can be segmented by drug development type: outsource, in-house. Among these, the outsource segment was accounted for the highest revenue generator in 2021. Pharmaceutical manufacturing market is further segmented by formulation: tablet, capsule, injectable, spray, suspension, powder, others. The tablet segment is estimated to account for the largest share of the global pharmaceutical manufacturing market. Based on administration route, the pharmaceutical manufacturing market is segmented into: oral, topical, parenteral, inhalation, others. The oral segment held the largest share of the global pharmaceutical manufacturing market in 2021 and is anticipated to hold its share during the forecast period. On the basis of prescription, the pharmaceutical manufacturing market also can be divided into: prescription medicines, over-the-counter (OTC) medicines. In 2021, the OTC medicines segment made up the largest share of revenue generated by the pharmaceutical manufacturing market. Pharmaceutical manufacturing market by therapy area is categorized into: cardiovascular diseases, pain, cancer, respiratory diseases, others. The pharmaceutical manufacturing market by age type can be segmented into: children and adolescent, adult, geriatric. Based on region, the pharmaceutical manufacturing market is further categorized into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.
Market Segmentation
By drug development type: outsource, in-house
By formulation: tablet, capsule, injectable, spray, suspension, powder, others
By administration route: oral, topical, parenteral, inhalation, others
By prescription: prescription medicines, over-the-counter (OTC) medicines
By therapy area: cardiovascular diseases, pain, cancer, respiratory diseases, others
By age type: children and adolescent, adult, geriatric
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
The report has also analysed the competitive landscape of the global pharmaceutical manufacturing market with some of the key players being AstraZeneca plc, Fujifilm Diosynth Biotechnologies U.S.A., Inc., Johnson & Johnson, Jubilant Life Sciences Limited, Lonza Group AG, Merck & Co., Inc., Pfizer, Inc., Roche Holding AG, Samsung Biologics Co., Ltd., Thermo Fisher Scientific, Inc., WuXi AppTec Co., Ltd., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook